Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
grade D 1.34 -1.47% -0.02
VSTM closed down 1.47 percent on Friday, December 13, 2019, on 51 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
See historical VSTM trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish -1.47%
Weak + Overbought Other -1.47%
Wide Bands Range Expansion -1.47%
Weak, Overbought and Reversal Signs Reversal -1.47%
Overbought Stochastic Strength -1.47%
Spinning Top Other -6.94%
Stochastic Reached Overbought Strength -6.94%
Older signals for VSTM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Medicine Biopharmaceutical Cancer Oncology Stem Cells Breast Cancer Ovarian Cancer Signal Transduction Cancer Research Metastasis Advanced Cancers Cancer Stem Cell Cancer Stem Cells Mesothelioma Mtor Phosphoinositide 3 Kinase

Is VSTM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.25
52 Week Low 0.83
Average Volume 1,783,808
200-Day Moving Average 1.65
50-Day Moving Average 1.17
20-Day Moving Average 1.22
10-Day Moving Average 1.37
Average True Range 0.11
ADX 28.08
+DI 26.11
-DI 19.08
Chandelier Exit (Long, 3 ATRs ) 1.17
Chandelier Exit (Short, 3 ATRs ) 1.16
Upper Bollinger Band 1.63
Lower Bollinger Band 0.81
Percent B (%b) 0.65
BandWidth 67.49
MACD Line 0.07
MACD Signal Line 0.06
MACD Histogram 0.0126
Fundamentals Value
Market Cap 49.57 Million
Num Shares 37 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -1.08
Price-to-Sales 0.00
Price-to-Book 2.72
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.43
Resistance 3 (R3) 1.43 1.40 1.42
Resistance 2 (R2) 1.40 1.38 1.40 1.41
Resistance 1 (R1) 1.37 1.36 1.36 1.37 1.40
Pivot Point 1.34 1.34 1.33 1.34 1.34
Support 1 (S1) 1.31 1.32 1.30 1.31 1.28
Support 2 (S2) 1.28 1.30 1.28 1.27
Support 3 (S3) 1.25 1.28 1.27
Support 4 (S4) 1.25